QuickView for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D3EFD0032CB15AA01F0040163408157F0%3Bjsessionid%3D7D16C35F2459D7EAE6FAF343D45E87E2%3Bjsessionid%3D3167845A0E3768D7575D02765CB82CA8%3Bjsessionid%3D8CF063BC1B746A0E7DD85BD20B755A4A%3Bjsessionid%3D66A26BAE54A7C8D578B718BDAB087D97%3Bjsessionid%3DB874809F8C1D176B623B2EEB7E20BB00%3Bjsessionid%3D9B91A3E13736DEF174BC5ECD8C0BA3CC%3Bjsessionid%3D5A40351691849CFC17575C7A8429AF66%3Bjsessionid%3D075D0CE4203BBB263841A8A48D0CB6D0%3Bjsessionid%3D67C01C30B35AE366B574338F458A88DA%3Bjsessionid%3D0A36F404EC0EC1F4A441FC614FBDDB12%3Bjsessionid%3D5C767E3D1B61CD17DEBDC69B87862118%3Bjsessionid%3DD764DE8A6F631110CF197512689FC7C7%3Bjsessionid%3D9A0A7B8FCF153D0679BC8E440E3B0D85%3Bjsessionid%3DE7B2E74B0CD5F71E9591F185118A5354 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D3EFD0032CB15AA01F0040163408157F0%3Bjsessionid%3D7D16C35F2459D7EAE6FAF343D45E87E2%3Bjsessionid%3D3167845A0E3768D7575D02765CB82CA8%3Bjsessionid%3D8CF063BC1B746A0E7DD85BD20B755A4A%3Bjsessionid%3D66A26BAE54A7C8D578B718BDAB087D97%3Bjsessionid%3DB874809F8C1D176B623B2EEB7E20BB00%3Bjsessionid%3D9B91A3E13736DEF174BC5ECD8C0BA3CC%3Bjsessionid%3D5A40351691849CFC17575C7A8429AF66%3Bjsessionid%3D075D0CE4203BBB263841A8A48D0CB6D0%3Bjsessionid%3D67C01C30B35AE366B574338F458A88DA%3Bjsessionid%3D0A36F404EC0EC1F4A441FC614FBDDB12%3Bjsessionid%3D5C767E3D1B61CD17DEBDC69B87862118%3Bjsessionid%3DD764DE8A6F631110CF197512689FC7C7%3Bjsessionid%3D9A0A7B8FCF153D0679BC8E440E3B0D85%3Bjsessionid%3DE7B2E74B0CD5F71E9591F185118A5354